The New York City Board of Health strain of Vaccinia is a viral strain used as a component of some smallpox vaccinations.L12747 ACAM2000, a percutaneously administered smallpox vaccine that was approved by the FDA in 2007, contains live antigens of this strain.L12747
In August 2024, ACAM2000 was additionally approved for the prevention of mpox infection in high-risk individuals.L51499
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Etanercept | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Etanercept. |
| Peginterferon alfa-2a | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Peginterferon alfa-2a. |
| Interferon alfa-n1 | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon alfa-n1. |
| Interferon alfa-n3 | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon alfa-n3. |
| Peginterferon alfa-2b | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Peginterferon alfa-2b. |
| Anakinra | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Anakinra. |
| Interferon gamma-1b | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon gamma-1b. |
| Interferon alfa-2a | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon alfa-2a. |
| Aldesleukin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Aldesleukin. |
| Adalimumab | The risk or severity of adverse effects can be increased when Adalimumab is combined with Smallpox (Vaccinia) Vaccine, Live. |
| Gemtuzumab ozogamicin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Gemtuzumab ozogamicin. |
| Pegaspargase | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Pegaspargase. |
| Infliximab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Infliximab. |
| Interferon beta-1b | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon beta-1b. |
| Interferon alfacon-1 | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon alfacon-1. |
| Trastuzumab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Trastuzumab. |
| Rituximab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Rituximab. |
| Basiliximab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Basiliximab. |
| Muromonab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Muromonab. |
| Ibritumomab tiuxetan | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Ibritumomab tiuxetan. |
| Tositumomab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Tositumomab. |
| Alemtuzumab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Alemtuzumab. |
| Cyclosporine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Cyclosporine. |
| Alefacept | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Alefacept. |
| Efalizumab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Efalizumab. |
| Antithymocyte immunoglobulin (rabbit) | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Antithymocyte immunoglobulin (rabbit). |
| Interferon alfa-2b | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Interferon alfa-2b. |
| Natalizumab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Natalizumab. |
| Daclizumab | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Daclizumab. |
| Phenylalanine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Phenylalanine. |
| Bortezomib | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Bortezomib. |
| Cladribine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Cladribine. |
| Carmustine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Carmustine. |
| Amsacrine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Amsacrine. |
| Bleomycin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Bleomycin. |
| Chlorambucil | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Chlorambucil. |
| Raltitrexed | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Raltitrexed. |
| Mitomycin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Mitomycin. |
| Bexarotene | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Bexarotene. |
| Vindesine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Vindesine. |
| Floxuridine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Floxuridine. |
| Indomethacin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Indomethacin. |
| Tioguanine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Tioguanine. |
| Vinorelbine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Vinorelbine. |
| Dexrazoxane | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Dexrazoxane. |
| Sorafenib | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Sorafenib. |
| Streptozocin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Streptozocin. |
| Trifluridine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Trifluridine. |
| Gemcitabine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Gemcitabine. |
| Teniposide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Teniposide. |
| Epirubicin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Epirubicin. |
| Chloramphenicol | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Chloramphenicol. |
| Lenalidomide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Lenalidomide. |
| Altretamine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Altretamine. |
| Zidovudine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Zidovudine. |
| Cisplatin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Cisplatin. |
| Oxaliplatin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Oxaliplatin. |
| Cyclophosphamide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Cyclophosphamide. |
| Vincristine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Vincristine. |
| Fluorouracil | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Fluorouracil. |
| Propylthiouracil | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Propylthiouracil. |
| Pentostatin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Pentostatin. |
| Methotrexate | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Methotrexate. |
| Carbamazepine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Carbamazepine. |
| Vinblastine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Vinblastine. |
| Linezolid | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Linezolid. |
| Imatinib | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Imatinib. |
| Clofarabine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Clofarabine. |
| Pemetrexed | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Pemetrexed. |
| Mycophenolate mofetil | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Mycophenolate mofetil. |
| Daunorubicin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Daunorubicin. |
| Irinotecan | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Irinotecan. |
| Methimazole | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Methimazole. |
| Etoposide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Etoposide. |
| Sulfasalazine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Sulfasalazine. |
| Dacarbazine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Dacarbazine. |
| Temozolomide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Temozolomide. |
| Penicillamine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Penicillamine. |
| Tacrolimus | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Tacrolimus. |
| Sirolimus | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Sirolimus. |
| Mechlorethamine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Mechlorethamine. |
| Azacitidine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Azacitidine. |
| Carboplatin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Carboplatin. |
| Dactinomycin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Dactinomycin. |
| Azathioprine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Azathioprine. |
| Doxorubicin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Doxorubicin. |
| Hydroxyurea | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Hydroxyurea. |
| Busulfan | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Busulfan. |
| Mycophenolic acid | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Mycophenolic acid. |
| Topotecan | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Topotecan. |
| Mercaptopurine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Mercaptopurine. |
| Thalidomide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Thalidomide. |
| Melphalan | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Melphalan. |
| Fludarabine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Fludarabine. |
| Leflunomide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Leflunomide. |
| Flucytosine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Flucytosine. |
| Capecitabine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Capecitabine. |
| Procarbazine | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Procarbazine. |
| Arsenic trioxide | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Arsenic trioxide. |
| Idarubicin | The risk or severity of infection can be increased when Smallpox (Vaccinia) Vaccine, Live is combined with Idarubicin. |